R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Clinical trial NCT05257018 · RECRUITING

Trial details

NCT number: NCT05257018
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2022-02-26
Primary completion: 2026-12-30
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.